シスタチンCとクレアチニンに基づく推定グルメルフィルタレーション率とアミオトロフィック横筋硬化症における生存率の違い:集団ベースのコホート研究
Yahui Zhu1,2, Jiongming Bai2,3, Hongfen Wang2
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Neurodegenerative disease management
|September 3, 2025
まとめ
推定グルメラー濾過率 (eGFRdiff) の大きな差異は,アミオトロフィック横筋硬化症 (ALS) 患者におけるより悪い結果と関連しています. EGFRdiffのモニタリングは,ALSの予後評価と効果的な管理に役立ちます.
科学分野:
- 腎臓科
- 神経学
- 臨床研究
背景:
- アミオトロフィック横筋硬化症 (ALS) は進行性神経変性疾患です.
- 球フィルタレーション率 (eGFR) によって推定される腎機能は,様々な健康状態において役割を果たします.
- ALS患者におけるeGFR測定値の差異の予後的意義は十分に確立されていません.
研究 の 目的:
- シスタチンCとクレアチニンに基づく推定球膜濾過率の違い (eGFRdiff) とアミオトロフィック横筋硬化症 (ALS) 患者のアウトカムとの関連を調査する.
- EGFRdiffが ALSの進行を予測するバイオマーカーとして機能するかどうかを判断する.
主な方法:
- 2014年1月から2019年12月の間に診断されたALS患者のコホートは2022年1月まで追跡されました.
- 絶対的な (eGFRabdiff) と相対的な (eGFRrediff) eGFRの差を計算した.
- EGFRdiffとALS生存率の関係を分析するために,コックスの比例リスクモデルが使用されました.
主要な成果:
- eGFRabdiffは患者の74. 7%で観察された.
- eGFRabdiffの標準偏差の上昇は,ALSの予後が悪いリスクの1. 9%の減少と関連していました (HR,0. 981).
- eGFR差の10%の増加は,予後不良のリスクの17.7%の減少と相関していた (HR, 0.823).
結論:
- eGFR (eGFRdiff) の有意な差異は,ALS患者の予後と関連しています.
- EGFRdiffのモニタリングは,ALSの予後分層化とパーソナライズされた管理戦略に役立ちます.
- この発見は,ALSの治療における腎機能モニタリングの潜在的な役割を強調しています.
関連する概念動画
Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Renal Clearance
1.3K
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
1.3K
Serum Studies: Renal Function Tests
43
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
43
Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280


